These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 9388225)
1. The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts. Toretsky JA; Kalebic T; Blakesley V; LeRoith D; Helman LJ J Biol Chem; 1997 Dec; 272(49):30822-7. PubMed ID: 9388225 [TBL] [Abstract][Full Text] [Related]
2. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis. Huang HJ; Angelo LS; Rodon J; Sun M; Kuenkele KP; Parsons HA; Trent JC; Kurzrock R PLoS One; 2011; 6(10):e26060. PubMed ID: 22022506 [TBL] [Abstract][Full Text] [Related]
3. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation. Silvany RE; Eliazer S; Wolff NC; Ilaria RL Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425 [TBL] [Abstract][Full Text] [Related]
4. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Prieur A; Tirode F; Cohen P; Delattre O Mol Cell Biol; 2004 Aug; 24(16):7275-83. PubMed ID: 15282325 [TBL] [Abstract][Full Text] [Related]
5. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Kinsey M; Smith R; Lessnick SL Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343 [TBL] [Abstract][Full Text] [Related]
6. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454 [TBL] [Abstract][Full Text] [Related]
7. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells. Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604 [TBL] [Abstract][Full Text] [Related]
8. Identification of target genes in their native cellular context: an analysis of EWS/FLI in Ewing's sarcoma. Owen LA; Lessnick SL Cell Cycle; 2006 Sep; 5(18):2049-53. PubMed ID: 16969112 [TBL] [Abstract][Full Text] [Related]
9. Alteration of mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing's sarcoma. Eliazer S; Spencer J; Ye D; Olson E; Ilaria RL Mol Cell Biol; 2003 Jan; 23(2):482-92. PubMed ID: 12509448 [TBL] [Abstract][Full Text] [Related]
10. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Riggi N; Cironi L; Provero P; Suvà ML; Kaloulis K; Garcia-Echeverria C; Hoffmann F; Trumpp A; Stamenkovic I Cancer Res; 2005 Dec; 65(24):11459-68. PubMed ID: 16357154 [TBL] [Abstract][Full Text] [Related]
11. Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1. Chan D; Wilson TJ; Xu D; Cowdery HE; Sanij E; Hertzog PJ; Kola I Br J Cancer; 2003 Jan; 88(1):137-45. PubMed ID: 12556973 [TBL] [Abstract][Full Text] [Related]
12. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Lessnick SL; Dacwag CS; Golub TR Cancer Cell; 2002 May; 1(4):393-401. PubMed ID: 12086853 [TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. Tirado OM; Mateo-Lozano S; Villar J; Dettin LE; Llort A; Gallego S; Ban J; Kovar H; Notario V Cancer Res; 2006 Oct; 66(20):9937-47. PubMed ID: 17047056 [TBL] [Abstract][Full Text] [Related]
14. IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells. Cironi L; Riggi N; Provero P; Wolf N; Suvà ML; Suvà D; Kindler V; Stamenkovic I PLoS One; 2008 Jul; 3(7):e2634. PubMed ID: 18648544 [TBL] [Abstract][Full Text] [Related]
15. Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors. Toretsky JA; Thakar M; Eskenazi AE; Frantz CN Cancer Res; 1999 Nov; 59(22):5745-50. PubMed ID: 10582694 [TBL] [Abstract][Full Text] [Related]
16. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423 [TBL] [Abstract][Full Text] [Related]
17. The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1. Arvand A; Welford SM; Teitell MA; Denny CT Cancer Res; 2001 Jul; 61(13):5311-7. PubMed ID: 11431376 [TBL] [Abstract][Full Text] [Related]
18. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Lessnick SL; Braun BS; Denny CT; May WA Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667 [TBL] [Abstract][Full Text] [Related]
19. EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model. González I; Vicent S; de Alava E; Lecanda F J Mol Med (Berl); 2007 Sep; 85(9):1015-29. PubMed ID: 17453169 [TBL] [Abstract][Full Text] [Related]
20. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells. Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]